Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor

CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor

US Patent 6750334 · Granted Jun 15, 2004

Estimated economic value: $1,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD19 variants2024
Means and methods for the treatment of angiogenesis-, fibrosis- and cancer-relat2023
Compositions and methods for treatment of cancer2023
Means and methods for treating and diagnosing fibrosis or fibrosis-associated di2023
Targeted cancer therapy2021
Compositions and methods for tumor transduction2021
Compositions and methods for treatment of cancer2020
Compositions and methods for treatment of cancer2019
Compositions and methods for tumor transduction2018
Compositions and methods for tumor transduction2018
Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological 2013
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand anti2012